2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | EUROPEAN JOURNAL OF CANCER EUR J CANCER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.6
59人评分
我要评分
声誉 9.4 影响力 8.3 速度 7.0 | |||||||||||||||||||||
| 期刊ISSN | 0959-8049 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1879-0852 | |||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 7.1 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：7.84 | |||||||||||||||||||||
| 2024-2025自引率 | 2.8%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 7.5 | |||||||||||||||||||||
| JCI期刊引文指标 | 1.59 | |||||||||||||||||||||
| h-index | 193 | |||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://www.sciencedirect.com/journal/european-journal-of-cancer | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/EJC | |||||||||||||||||||||
| 作者指南网址 | https://www.sciencedirect.com/journal/european-journal-of-cancer/publish/guide-for-authors | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Population impact of PSA screening: Evidence beyond clinical trials Author: Vaccarella, Salvatore; Li, Mengmeng; Auvinen, Anssi; Dal, Luigino Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116615 Clinical utility of large language models in metastatic prostate cancer: A multicenter expert validation for decision support Author: Chen, Yinsong; He, Kangwen; Qu, Weinuo; Ma, Luping; Su, Xing; Liu, Xinqi; Kang, Zhen; Li, Feng; Yan, Junrong; Wang, Zhibo; Li, Jing; Li, Zhen Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116667 Stereotactic body radiotherapy versus hepatic resection for recurrent small hepatocellular carcinoma: A post-hoc analysis with propensity score adjustment from two randomized trials Author: Fu, Yizhen; Liu, Shiliang; Chen, Jinbin; Zhang, Li; Wang, Juncheng; Pan, Yangxun; Xu, Li; Fang, Aiping; Chen, Minshan; Zhang, Yaojun; Xi, Mian Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116675 MuTriM: A multiscale deep learning model integrating longitudinal radiomics and pathomic features for predicting recurrence and adjuvant radiation benefit in breast cancer Author: Wang, Xiangxue; Chen, Liya; Sun, Jingwen; Khalighi, Sirvan; Dam, Tanmoy; Maurya, Himanshu; Pathak, Tilak; Lu, Cheng; Gandhi, Shipra; Badve, Sunil; Zhao, Shen; Yang, Wentao; Xu, Jun; Madabhushi, Anant; Song, Bolin Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116679 | |||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足EUROPEAN JOURNAL OF CANCER的语言要求，还能让EUROPEAN JOURNAL OF CANCER编辑和审稿人得到更好的审稿体验，让稿件最大限度地被EUROPEAN JOURNAL OF CANCER编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢（1篇） 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
| 通讯方式 | ELSEVIER SCI LTD, 125 London Wall, London, England, EC2Y 5AS | |||||||||||||||||||||
| 出版商 | Elsevier Ltd | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Semimonthly | |||||||||||||||||||||
| 出版年份 | 1965 | |||||||||||||||||||||
| 年文章数 | 329点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 34.62% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 92.40% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) 收录数据库： Scopus; Medline Science Citation Index Expanded (SCIE) SCImago Journal Rank (SJR) SNIP | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0959-8049%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 期刊官网数据： 平均Submission to first decision: 9 days; Submission to decision after review: 34 days; Submission to acceptance: 66 days; Acceptance to online publication: 4 days; 网友分享经验： 平均1.0个月 来源Elsevier官网： 平均5.3周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约28% | |||||||||||||||||||||
| APC文章处理费信息 | 版面费：Article Publishing Charge (APC): USD 4,480 (excluding taxes). The amount you pay may be reduced during submission if applicable. | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在EUROPEAN JOURNAL OF CANCER顺利发表。
快看看作者怎么说吧：服务好评 论文致谢（1篇） 。 提交文稿 | |||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均7.3周 | |||||||||||||||||||||
| 编辑信息 | Editor-in-Chief Alexander M. M. Eggermont, MD, PhD University Medical Centre Utrecht, Utrecht, Netherlands Editorial Office EJC Editorial Office Elsevier Ltd, Nielsen House, John Smith Drive, Oxford Business Park South, Oxford OX4 2WB, UK | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Population impact of PSA screening: Evidence beyond clinical trials Author: Vaccarella, Salvatore; Li, Mengmeng; Auvinen, Anssi; Dal, Luigino Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116615 PubMed DOI |
| 2. | Clinical utility of large language models in metastatic prostate cancer: A multicenter expert validation for decision support Author: Chen, Yinsong; He, Kangwen; Qu, Weinuo; Ma, Luping; Su, Xing; Liu, Xinqi; Kang, Zhen; Li, Feng; Yan, Junrong; Wang, Zhibo; Li, Jing; Li, Zhen Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116667 PubMed DOI |
| 3. | Stereotactic body radiotherapy versus hepatic resection for recurrent small hepatocellular carcinoma: A post-hoc analysis with propensity score adjustment from two randomized trials Author: Fu, Yizhen; Liu, Shiliang; Chen, Jinbin; Zhang, Li; Wang, Juncheng; Pan, Yangxun; Xu, Li; Fang, Aiping; Chen, Minshan; Zhang, Yaojun; Xi, Mian Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116675 PubMed DOI |
| 4. | MuTriM: A multiscale deep learning model integrating longitudinal radiomics and pathomic features for predicting recurrence and adjuvant radiation benefit in breast cancer Author: Wang, Xiangxue; Chen, Liya; Sun, Jingwen; Khalighi, Sirvan; Dam, Tanmoy; Maurya, Himanshu; Pathak, Tilak; Lu, Cheng; Gandhi, Shipra; Badve, Sunil; Zhao, Shen; Yang, Wentao; Xu, Jun; Madabhushi, Anant; Song, Bolin Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116679 PubMed DOI |
| 5. | Potential induction of protective anti-tumor immune response in cancer patients by oncolytic viruses containing the GGTA1 gene Author: Galili, Uri; Zhao, Yongxiang Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 236, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116251 PubMed DOI |
| 6. | Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancer Author: Ai, Xinghao; Guo, Renhua; Zhang, Liang; Fang, Jian; Zhang, Yiping; Chen, Jianhua; Zhao, Jun; Ye, Feng; Wang, Shumei; Shi, Meiqi; Zhang, Xinwei; Zhang, Fang; Li, Jiakui; Wang, Li; Guo, Xuejie; Xu, Lingmei; Duan, Xianghui; Hu, Yan; Lu, Shun Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 235, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116221 PubMed DOI |
| 7. | SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217) Author: Chiang, Nai-Jung; Su, Yung-Yeh; Ho, I. -Wei; Bai, Li-Yuan; Li, Chung-Pin; Chen, Jen-Shi; Hsiao, Chin-Fu; Tsou, Hsiao-Hui; Hsu, Chiun; Chiu, Tai-Jan; Hsieh, Yao-Yu; Rau, Kun-Ming; Ho, Ching-Liang; Shan, Yan-Shen; Chen, Li-Tzong Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 235, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116229 PubMed DOI |
| 8. | Regulation of epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: Role of key molecules in tumor differentiation and therapy Author: Ling, Qi; Ong, Meiching; Konukiewitz, Bjoern; Braun, Ruediger; Marquardt, Jens-Uwe; Lehnert, Hendrik; Kalthoff, Holger; Ungefroren, Hendrik Journal: EUROPEAN JOURNAL OF CANCER. 2025; Vol. 225`, Issue , pp. -. DOI: 10.1016/j.ejca.2025.115561 PubMed DOI |
| 9. | Letter Re: Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial Author: Wang, Huansheng; Wang, Na Journal: EUROPEAN JOURNAL OF CANCER. 2025; Vol. 224, Issue , pp. -. DOI: 10.1016/j.ejca.2025.115515 PubMed DOI |
| 10. | Letter re: The prognostic and clinical significance of substantial lymphovascular space invasion in early-stage endometrial carcinoma Author: Liu, Wei; Yang, Yuwei Journal: EUROPEAN JOURNAL OF CANCER. 2025; Vol. 222, Issue , pp. -. DOI: 10.1016/j.ejca.2025.115446 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共183条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
